Computational Methods for Cancer Neoantigen Prediction

Area of Science:

• Oncology
• Immunology
• Bioinformatics

Background:

• Neoantigens arise from tumor-specific mutations and are recognized by the immune system, driving antitumor responses.
• The rise of cancer immunotherapies has intensified the focus on neoantigens.
• Computational tools are crucial for identifying and prioritizing neoantigens for experimental validation.

Purpose of the Study:

• To detail the in silico identification and prioritization of potential neoantigens.
• To review and compare current bioinformatics tools and pipelines for neoantigen prediction in humans and mice.
• To discuss the technical challenges and future improvements in neoantigen prediction, particularly with AI integration.

Main Methods:

• In silico identification of neoantigens using computational tools.
• Comparison of leading bioinformatics pipelines for neoantigen prediction.
• Analysis of artificial intelligence applications in neoantigen discovery.

Main Results:

• Key steps for in silico neoantigen identification are outlined.
• A comparison of frequently used and cutting-edge neoantigen prediction tools is provided.
• Technical limitations and AI-driven advancements in neoantigen prediction are discussed.

Conclusions:

• Advances in immunomics and computational biology are essential for personalized cancer immunotherapy.
• Improved neoantigen prediction will enhance the clinical application of immunotherapies.
• AI integration promises significant improvements in neoantigen discovery and cancer patient outcomes.